Jia Jie Biomedical Co Ltd (4109) — Cash Flow Reinvestment Rate
Jia Jie Biomedical Co Ltd (4109) has a Cash Flow Reinvestment Rate of 3.87x as of December 2025, reinvesting NT$43.81 Million (capex NT$28.47 Million plus investments NT$15.34 Million) from operating cash flow of NT$11.32 Million. Check Jia Jie Biomedical Co Ltd (4109) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jia Jie Biomedical Co Ltd Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Jia Jie Biomedical Co Ltd across 6 annual periods. Explore Jia Jie Biomedical Co Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Jia Jie Biomedical Co Ltd (2015–2025)
Year-by-year capital reinvestment analysis for Jia Jie Biomedical Co Ltd. For live market cap and broader valuation context, see Jia Jie Biomedical Co Ltd (4109) total market value.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 8.62x | NT$184.01 Million | NT$21.34 Million | NT$85.50 Million | ▲ +336.0% |
| 2024 | 1.98x | NT$87.70 Million | NT$44.35 Million | NT$19.63 Million | ▼ -94.8% |
| 2021 | 37.72x | NT$164.94 Million | NT$4.37 Million | NT$1.52 Million | ▲ +519.3% |
| 2020 | 6.09x | NT$165.05 Million | NT$27.10 Million | NT$1.63 Million | ▼ -15.8% |
| 2019 | 7.23x | NT$178.78 Million | NT$24.71 Million | NT$3.05 Million | ▲ +114.6% |
| 2015 | 3.37x | NT$277.22 Million | NT$82.22 Million | NT$273.85 Million | — |